Pasokan Pabrik Dapagliflozin Powder CAS 461432-26-8 dengan Harga Baik
Deskripsi Produk
Dapagliflozin (ForxigaTM) is a new antidiabetic drug jointly developed by Bristol-Myers Squibb and AstraZeneca, being approved by the European Medicines Agency (EMA) on November 12, 2012.It is also the first approved SGLT2 inhibitor for the treatment of type II diabetes, being an important option in the treatment of diabetes, and is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes.
Nama produk | Dapagliflozin |
CAS | 461432-26-8 |
Penampilan | bubuk putih |
Periksa | 99% |
Penyimpanan | Dingin dan Lindungi dari cahaya |
Fungsi dan Aplikasi
Dapagliflozin adalah obat yang digunakan untuk mengobati diabetes tipe 2.Although dapagliflozin's method of action would operate on both types of diabetes and other conditions resulting in hyperglycemia Meskipun dapagliflozin's method of action would operate on both types of diabetes, the current clinical trials specifically exclude participants with type 1 diabetes.